What is Asset Entities's medical device — change in fair value?

Asset Entities (ASST) reported medical device — change in fair value of $0 in Q1 2026.

What does medical device — change in fair value mean?

This metric captures the periodic adjustments in the valuation of assets or liabilities held by the segment that are marked to market. It reflects unrealized gains or losses resulting from market fluctuations or revaluations of specific holdings. This figure highlights the volatility and financial risk associated with the segment's asset portfolio.

Asset Entities ASST Medical Device — Change in fair value

Other segment segments

Corporate & Other

$490K—

Asset Management

$0—

Similar metrics at other companies

WGSChange in fair value of financial liabilities

$2.54M+331%

ENVAChange In Fair Value

$346.18M+8.4%

RUMChange In Fair Value Of Digital Assets

$4.07M+139%

RUMChanges In Fair Value Of Derivative

-$9.7M-121%

AGMNet Change In Fair Value, Trading Securities, Hedged Assets, Financial Derivatives And Loans Held For Sale

-$38.33M-135%

LNCChanges in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans

$179M+299%

Other financials

Income statement

See full

Revenue$2.8M+1,516%

Operating income-$313.1M-7,588%

Net income-$265.9M-6,993%

EPS (diluted)-$4.53-175%

Balance sheet

See full

Cash & equivalents$95.1M+982%

Total debt$3.4M—

Total equity$714.8M+3,548%

Total assets$1.1B+21,931%

Cash flow

See full

Operating cash flow-$31.0M-455%

CapEx--100%

Free cash flow-$31.0M-450%

Valuation

See full

Market cap$1.02B+1,127%

Enterprise value$932M—

P/S118.1×—

Profitability

See full

Operating margin-6,563%-18,545pp

Net margin-8,022.9%-20,291pp

FCF margin-3,856.7%—

Returns & leverage

See full

Return on equity-189.4%+139pp

Debt / equity0×—

Current ratio11.4×+1.7×

Where this comes from

Reported directly by Asset Entities in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss.

The official record: Asset Entities’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Asset Entities's medical device — change in fair value.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Asset Entities's medical device — change in fair value?: Asset Entities (ASST) reported medical device — change in fair value of $0 in Q1 2026.
What does medical device — change in fair value mean?: This metric captures the periodic adjustments in the valuation of assets or liabilities held by the segment that are marked to market. It reflects unrealized gains or losses resulting from market fluctuations or revaluations of specific holdings. This figure highlights the volatility and financial risk associated with the segment's asset portfolio.